{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:34:31Z","timestamp":1776836071736,"version":"3.51.2"},"reference-count":45,"publisher":"Frontiers Media SA","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":131,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Unrestrictive research grant from Roche Farma.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1111\/tri.12586","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T07:15:32Z","timestamp":1428736532000},"page":"1042-1054","source":"Crossref","is-referenced-by-count":33,"title":["Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice"],"prefix":"10.3389","volume":"28","author":[{"given":"Mario","family":"Fern\u00e1ndez-Ruiz","sequence":"first","affiliation":[{"name":"Unit of Infectious Diseases; Hospital Universitario \u201c12 de Octubre\u201d; Instituto de Investigaci\u00f3n Hospital \u201c12 de Octubre\u201d (i+12); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Arias","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cMarqu\u00e9s de Valdecilla\u201d; Instituto de Formaci\u00f3n e Investigaci\u00f3n \u201cMarqu\u00e9s de Valdecilla\u201d (IFIMAV); Santander Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Campistol","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Clinic; Institut d'Investigacions Biom\u00e8diques \u201cAugust Pi i Sunyer\u201d (IDIBAPS); Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Microbiology; Hospital Cl\u00ednico Universitario; Instituto de Investigaci\u00f3n Sanitaria INCLIVA; University of Valencia; Valencia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"G\u00f3mez-Huertas","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Central de Asturias; Oviedo Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"G\u00f3mez-M\u00e1rquez","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario Son Espases; Palma de Mallorca Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Fundaci\u00f3 Puigvert; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cCarlos Haya\u201d; M\u00e1laga Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Bernal-Blanco","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cVirgen del Roc\u00edo\u201d; Instituto de Biomedicina de Sevilla (IBIS); Sevilla Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Cofan","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Clinic; Institut d'Investigacions Biom\u00e8diques \u201cAugust Pi i Sunyer\u201d (IDIBAPS); Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Jimeno","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cVirgen de la Arrixaca\u201d; El Palmar; Murcia Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Franco-Esteve","sequence":"additional","affiliation":[{"name":"Unit of Nephrology; Hospital General de Alicante; Alicante Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201c12 de Octubre\u201d; Instituto de Investigaci\u00f3n Hospital \u201c12 de Octubre\u201d (i+12); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc J.","family":"Moreso","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitari Vall d'Hebron; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"G\u00f3mez-Alamillo","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cMarqu\u00e9s de Valdecilla\u201d; Instituto de Formaci\u00f3n e Investigaci\u00f3n \u201cMarqu\u00e9s de Valdecilla\u201d (IFIMAV); Santander Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mendiluce","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Cl\u00ednico Universitario; Valladolid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Luna-Huerta","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Hospital Universitario \u201cInfanta Cristina\u201d; Badajoz Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases; Hospital Universitario \u201c12 de Octubre\u201d; Instituto de Investigaci\u00f3n Hospital \u201c12 de Octubre\u201d (i+12); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the OPERA Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"issue":"Suppl. 4","key":"10.1111\/tri.12586-BIB0001|tri12586-cit-0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0002|tri12586-cit-0002","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The \u2018indirect\u2019 effects of cytomegalovirus infection","volume":"9","author":"Freeman","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0003|tri12586-cit-0003","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.12586-BIB0004|tri12586-cit-0004","doi-asserted-by":"crossref","first-page":"pi=19896","DOI":"10.2807\/ese.16.25.19896-en","article-title":"Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003","volume":"16","author":"Lopo","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1111\/tri.12586-BIB0005|tri12586-cit-0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/B:EJEP.0000013253.56343.6f","article-title":"Is there a change in cytomegalovirus seroepidemiology in Spain?","volume":"19","author":"Ory","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/tri.12586-BIB0006|tri12586-cit-0006","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0007|tri12586-cit-0007","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200\u00a0days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0008|tri12586-cit-0008","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/j.1600-6143.2012.04231.x","article-title":"Efficacy and safety of maribavir dosed at 100\u00a0mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial","volume":"12","author":"Winston","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0009|tri12586-cit-0009","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0010|tri12586-cit-0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0011|tri12586-cit-0011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0012|tri12586-cit-0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial","volume":"93","author":"Witzke","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0013|tri12586-cit-0013","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.eimc.2011.05.022","article-title":"GESITRA-SEIMC\/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients","volume":"29","author":"Torre-Cisneros","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/tri.12586-BIB0014|tri12586-cit-0014","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0015|tri12586-cit-0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0b013e31828ee12e","article-title":"International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines","volume":"95","author":"Le Page","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0016|tri12586-cit-0016","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/605633","article-title":"Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease","volume":"49","author":"Manuel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.12586-BIB0017|tri12586-cit-0017","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0018|tri12586-cit-0018","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"Suppl. 7","key":"10.1111\/tri.12586-BIB0019|tri12586-cit-0019","first-page":"1","article-title":"European best practice guidelines for renal transplantation (part 1)","volume":"15","author":"European Renal Association","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12586-BIB0020|tri12586-cit-0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1111\/tri.12586-BIB0021|tri12586-cit-0021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/TP.0b013e318200000c","article-title":"Universal prophylaxis is cost effective in cytomegalovirus serology-positive kidney transplant patients","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0022|tri12586-cit-0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-3062.2010.00573.x","article-title":"Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study","volume":"13","author":"Delgado","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12586-BIB0023|tri12586-cit-0023","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0024|tri12586-cit-0024","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/lt.23540","article-title":"Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience","volume":"18","author":"Wadhawan","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.12586-BIB0025|tri12586-cit-0025","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/ajt.12388","article-title":"Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients","volume":"13","author":"Manuel","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0026|tri12586-cit-0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12586-BIB0027|tri12586-cit-0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-3062.2006.00169.x","article-title":"Cytomegalovirus infection in renal transplant recipients","volume":"8","author":"Carstens","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12586-BIB0028|tri12586-cit-0028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2010.00533.x","article-title":"Cytomegalovirus risk factors in renal transplantation with modern immunosuppression","volume":"12","author":"Bataille","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12586-BIB0029|tri12586-cit-0029","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/591532","article-title":"Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation","volume":"47","author":"San Juan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.12586-BIB0030|tri12586-cit-0030","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000000570","article-title":"Evaluation of low- versus high-dose valganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients","author":"Gabardi","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0031|tri12586-cit-0031","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/tid.12349","article-title":"Increased risk of breakthrough infection among cytomegalovirus donor-positive\/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis","volume":"17","author":"Stevens","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12586-BIB0032|tri12586-cit-0032","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/tri.12586-BIB0033|tri12586-cit-0033","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-6143.2008.02513.x","article-title":"Interlaboratory comparison of cytomegalovirus viral load assays","volume":"9","author":"Pang","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0034|tri12586-cit-0034","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1373\/clinchem.2009.124743","article-title":"A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories","volume":"55","author":"Caliendo","year":"2009","journal-title":"Clin Chem"},{"key":"10.1111\/tri.12586-BIB0035|tri12586-cit-0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.12586-BIB0036|tri12586-cit-0036","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/tri.12586-BIB0037|tri12586-cit-0037","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1086\/382753","article-title":"Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients","volume":"189","author":"Boivin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.12586-BIB0038|tri12586-cit-0038","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jcv.2011.12.019","article-title":"Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200\u00a0days of valganciclovir prophylaxis","volume":"53","author":"Boivin","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1111\/tri.12586-BIB0039|tri12586-cit-0039","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/cit945","article-title":"A direct and indirect comparison meta-analysis on the efficacy\u00a0of cytomegalovirus preventive strategies in solid organ transplant","volume":"58","author":"Florescu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1111\/tri.12586-BIB0040|tri12586-cit-0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.tp.0000438197.38413.f2","article-title":"Risk factors for late-onset cytomegalovirus infection or disease in kidney transplant recipients","volume":"97","author":"Jamal","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0041|tri12586-cit-0041","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R\u2212 kidney transplant\u00a0recipients is associated with long-term reduction\u00a0in cytomegalovirus disease: two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0042|tri12586-cit-0042","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1600-6143.2004.00451.x","article-title":"Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12586-BIB0043|tri12586-cit-0043","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/tid.12226","article-title":"Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+\/R\u2212): experience from the RESITRA-REIPI cohort","volume":"16","author":"Meije","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12586-BIB0044|tri12586-cit-0044","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0000000000000160","article-title":"Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment","volume":"98","author":"Stern","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.12586-BIB0045|tri12586-cit-0045","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.182.3.1548","article-title":"Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes","volume":"182","author":"Walker","year":"2009","journal-title":"J Immunol"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12586","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12586\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:04:22Z","timestamp":1691579062000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12586","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,23]]}}}